Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis

Abstract Background Oral iron is recommended as first line treatment of anemia in non-dialysis chronic kidney disease (ND-CKD) patients. Sucrosomial® iron, a new generation oral iron with high absorption and bioavailability and a low incidence of side effects, has shown to be not inferior to intrave...

Full description

Bibliographic Details
Main Authors: Eleonora Riccio, Massimo Sabbatini, Ivana Capuano, Angela Maria Pellegrino, Luigi Annicchiarico Petruzzelli, Antonio Pisani
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Nephrology
Subjects:
Cost-minimization analysis
Oral sucrosomial iron
Intravenous iron
Anaemia
Iron deficiency
Online Access:http://link.springer.com/article/10.1186/s12882-020-01716-w

Internet

http://link.springer.com/article/10.1186/s12882-020-01716-w

Similar Items